DUBA: a deubiquitinase that regulates type I interferon production

  • Science. 2007 Dec 7;318(5856):1628-32. doi: 10.1126/science.1145918.
Nobuhiko Kayagaki  1 ,  Qui Phung ,  Salina Chan ,  Ruchir Chaudhari ,  Casey Quan ,  Karen M O'Rourke ,  Michael Eby ,  Eric Pietras ,  Genhong Cheng ,  J Fernando Bazan ,  Zemin Zhang ,  David Arnott ,  Vishva M Dixit
Affiliations
  • 1. Department of Physiological Chemistry, Genentech, South San Francisco, CA 94080, USA.
Abstract

Production of type I interferon (IFN-I) is a critical host defense triggered by pattern-recognition receptors (PRRs) of the innate immune system. Deubiquitinating enzyme A (DUBA), an ovarian tumor domain-containing deubiquitinating enzyme, was discovered in a small interfering RNA-based screen as a regulator of IFN-I production. Reduction of DUBA augmented the PRR-induced IFN-I response, whereas ectopic expression of DUBA had the converse effect. DUBA bound tumor necrosis factor receptor-associated factor 3 (TRAF3), an adaptor protein essential for the IFN-I response. TRAF3 is an E3 ubiquitin Ligase that preferentially assembled lysine-63-linked polyubiquitin chains. DUBA selectively cleaved the lysine-63-linked polyubiquitin chains on TRAF3, resulting in its dissociation from the downstream signaling complex containing TANK-binding kinase 1. A discrete ubiquitin interaction motif within DUBA was required for efficient deubiquitination of TRAF3 and optimal suppression of IFN-I. Our data identify DUBA as a negative regulator of innate immune responses.